Nasdaq100 was selling short term to support the demand in supply after a long term buying power without any potential supply. The long positions that have been taken during Q3 were drastic to exhaustion of the price. As companies closed doors for festive season we had decline in the and around Q1 of 2022 probably from the 15th of January we will see a new fleet of buyers which will lead to appreciation of the price the we will more momentum in the US technology due to hike in prices during the first quarter considering the rises in the US government and the world as whole. Pharmaceutical companies joined the US technology where during the course of Covid19 we have lost momentum in retail sales, with the mandatory vaccination people will opt for online shopping which automatically adds value to the Nasdaq stock market. So we will see potential gains in momentum for buyers in Nasdaq.